FDA Inspection 735060 — UF Reproductive Medicine at Springhill

UF Reproductive Medicine at Springhill — FEI 3003926999

The FDA completed an inspection of UF Reproductive Medicine at Springhill on July 18, 2011 in Gainesville, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 18, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Gainesville, FL (United States)

Citations

IDCFRDescription
1222921 CFR 1271.50(a)Determination based on screening and testing